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Abstract  19 
Deficiencies in protein and energy intakes are partly responsible for age-related sarcopenia. We 20 
investigated the effects of supplements matched in essential amino acid (EAA) content (7.5 g) on 21 
energy intake and appetite. Ten women aged 69.2 ± 2.7 years, completed three trials in a 22 
randomised, crossover design. Composite appetite scores, peptide-YY (PYY), and insulin 23 
responses to a 200 ml whey protein isolate (WP, 275 kJ), a 50 ml EAA gel (GEL, 478 kJ) or 24 
nothing as the control condition (CON) were investigated over one hour, followed by an ad libitum 25 
breakfast. Energy intake at breakfast (CON 1957 ± 713, WP 1413 ± 623, GEL 1963 ± 611 kJ) was 26 
higher in CON and GEL than in WP (both P = 0.006). After accounting for supplement energy 27 
content, energy intake in GEL was higher than in CON (P = 0.0006) and WP (P = 0.0008). Time-28 
averaged area under the curve for composite appetite scores (CON 74 ± 20, WP 50 ± 22, GEL 60 29 
± 16 mm) was higher in CON than WP (P = 0.015). Time-averaged area under the curve for PYY 30 
(CON 87 ± 13, WP 119 ± 27, GEL 97 ± 22 pg·mL-1) was higher in WP than CON (P = 0.009) and 31 
GEL (P = 0.012). In conclusion, supplementation with WP facilitated an increase in protein intake, 32 
whereas supplementation with GEL increases in both energy and protein intakes, when consumed 33 
before an ad libitum breakfast. Such findings, highlight potential gel-based EAA supplementation 34 
intake for addressing age-related sarcopenia. 35 
 36 
Key words: Sarcopenia; Undernutrition; Malnutrition; Leucine; Ageing; Protein37 
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Introduction  38 
Age-related sarcopenia, characterised by a decline in muscle mass and function or strength (Cruz-39 
Jentoft et al. 2010), contributes to poor health in older people (Janssen et al. 2004b). As identified 40 
in a recent review by Naseeb and Volep (2017), dietary protein intake and physical activity play a 41 
key role in the management of sarcopenia. Similarly to protein, optimal energy intake is crucial 42 
for the maintenance of muscle mass and health (Dahany et al. 2014; Thalacker‐Mercer et al. 2014; 43 
Baum et al. 2016). Nevertheless, older people have reduced appetite and energy intake compared 44 
to the young (Giezenaar et al. 2016), whilst deficiencies in energy and protein intakes are 45 
contributing factors to frailty (Beasley et al. 2010; Bauer et al. 2013; Bonnefoy et al. 2015). 46 
Older women do not achieve the current Recommended Daily Allowance (RDA) for protein intake 47 
(Kerstetter et al. 2003; Morley et al. 2010; Pasiakos et al. 2015; Farsijani et al. 2016). Given that 48 
a lack of muscle responsiveness can be overcome with larger doses than the current RDA for 49 
protein (Hulmi et al. 2010; Cramer et al. 2016; Loenneke et al. 2016), an increase in protein intake 50 
may be a viable strategy for managing sarcopenia (Janssen et al. 2004a; Clark et al. 2010; Lang et 51 
al. 2010; Lieffers et al. 2012). Indeed, evidence supports an increase in daily protein intake from 52 
the current RDA (0.8 g·kg-1·d-1) to 1.0-1.6 g·kg-1·d-1 (Bauer et al. 2013; Deutz et al. 2014; 53 
Loenneke et al. 2016; Traylor et al. 2018). Consumption of at least 0.4 g·kg-1·BM of high quality 54 
protein per meal (Moore et al. 2014; Phillips 2015; Lancha Jr et al. 2016) is also recommended. 55 
This is primarily due to their high essential amino acid (EAA) content which optimises muscle 56 
protein synthesis (Breen et al. 2011; Churchward-Venne et al. 2014; Paddon-Jones et al. 2014; Xu 57 
et al. 2015; Murphy et al. 2016; Phillips 2016; Hamarsland et al. 2017). However, current evidence 58 
is limited regarding the beneficial impact of protein or EAA supplementation alone on the muscle 59 
mass and strength of predominantly healthy (Tieland et al. 2017) or clinical older populations 60 
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(Ferrando et al. 2010; Cramer et al. 2016). Potential explanations for these discrepancies may 61 
include a compensatory caloric redistribution (Fiatarone Singh et al. 2000) or partial caloric 62 
redistribution (Cramer et al. 2016) due to appetite suppression.  63 
Ageing is associated with a progressive decrease in appetite and fluctuations in appetite regulating 64 
hormones (Benelam 2009; Ahmed et al. 2010; Akimoto et al. 2010; Donini et al. 2013; Giezenaar 65 
et al. 2016). Taking into account that dietary and whey proteins enhance satiety (Veldhorst et al. 66 
2008; Mollahosseini et al. 2017), and in a dose response manner (Veldhorst et al. 2009; Paddon-67 
Jones et al. 2014), the appetite of older people may be compromised further. A full investigation 68 
of the satiety control mechanisms, which have been discussed elsewhere (Sukkar et al. 2013; 69 
Tremblay et al. 2015), is beyond the scope of this paper. However, a postprandial increase in 70 
peptide YY (PYY), probably due to an increase in amino acids in the gastrointestinal tract (Moran 71 
et al. 2011) following consumption of dietary protein, plays a key role for reductions in energy 72 
intake (Leidy et al. 2015; Phillips et al. 2016). Appetite of older women may be suppressed further 73 
since postprandial PYY increases to greater extent than in younger women (Hickson et al. 2016). 74 
Recently, we have shown that ingestion of EAA gel-based nutritional prototypes providing 7.5 g 75 
of EAA by older women prior to consumption of an ad libitum breakfast (ALB) did neither result 76 
in an increase in PYY nor a decrease in energy intake compared to a control condition (Ispoglou 77 
et al. 2017). Whey proteins may be considered the highest quality proteins (Hoffman et al. 2004; 78 
Hulmi et al. 2010) however they reduce appetite partly due to their high amino acid content. We 79 
therefore hypothesised that a gel containing the same total amount of EAAs as in approximately 80 
15 g of whey protein would affect appetite and appetite hormone responses to a lesser degree than 81 
the whey protein supplement, and this in turn would facilitate an increase in both protein and 82 
energy intake when taken before an ALB. 83 
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 84 
Materials and methods  85 
This investigation was conducted in accordance with the guidelines laid down in the Declaration 86 
of Helsinki. All procedures were approved by the University Faculty Research Ethics Committee 87 
and written informed consent was obtained from all participants. Study participants were 88 
independently living female older adults aged between 65 and 75 years, free from vascular and 89 
metabolic disease, and of good health. Participants were excluded if they smoked, had used 90 
estrogens within the previous three months, or were lactose intolerant. Participants were asked to 91 
avoid alcohol and intensive physical activity during the 24 hours prior to experimental trials. All 92 
trials commenced between 07:30 am and 09:00 am after an overnight fast of at least 10 hours. 93 
Participants exerted themselves minimally when travelling to the laboratory, using motorised 94 
transport where possible.  95 
 96 
Preliminary screening and anthropometry 97 
The first visit to the laboratory involved an initial briefing and screening process. Participants were 98 
provided with information on the study procedures and given a detailed overview before each trial. 99 
Baseline stature (to the nearest cm) and body mass (to the nearest kg) were recorded by a 100 
stadiometer (Seca 220, Hamburg, Germany) and scales (Seca 220, Hamburg, Germany). Resting 101 
heart rate, systolic and diastolic blood pressure were measured alongside these variables, using an 102 
automatic sphygmomanometer (Omron Healthcare Ltd, Kyoto, Japan).  103 
 104 
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Experimental protocol  105 
Older women (n=10) (see Table 1 for anthropometric characteristics) completed three trials each 106 
separated by a minimum of three days in a randomised, crossover design.  Participants recorded 107 
food and fluid consumed in the 24 h prior to the first experimental trial and replicated this for all 108 
subsequent trials. They were also asked to avoid intensive physical activity during the same time 109 
period. All trials commenced between 07:30 am and 09:00 am after an overnight fast of at least 110 
10 h. Participants exerted themselves minimally when travelling to the laboratory, using motorised 111 
transport where possible. Verbal confirmation of the dietary and exercise standardisation was 112 
obtained at the beginning of each experimental trial. For screening purposes during the initial visit, 113 
all participants had their blood pressure measured using a manual sphygmomanometer (Accoson 114 
Greenlight 300, Accoson, United Kingdom). Fingertip capillary blood samples were also analysed 115 
for fasting levels of total cholesterol, high-density lipoprotein, low-density lipoprotein, 116 
triglycerides and glucose using a Cholestech LDX (Alere San Diego, Inc., San Diego, CA) 117 
analyser. For an outline of tests and testing procedures, see Figure 1. 118 
Upon arrival, participants rested in a supine position for 15 minutes. Appetite sensations, plasma 119 
insulin and PYY responses to a 200 ml WP isolate (275 kJ) made with 178 ml water and 21.2 g of 120 
WP powder , a 50 ml GEL (478 kJ), and a CON were investigated over the course of one hour, 121 
followed by an ALB. During the CON trial, nothing was consumed by participants before the 122 
ALB. The inclusion of an isocaloric placebo and matching for volume were dismissed as a means 123 
to enhance the ecological validity of the study. In addition, it has been shown that 375 ml water 124 
pre-load 30 min before a meal does not negatively affect energy intake in older women (Walleghen 125 
et al. 2007). The WP powder was purchased from MyProtein (key nutritional information per 100g  126 
was: energy 1558 kJ, fat 0.5 g, carbohydrate 4.1 g, protein 86 g and salt 0.5 g). The EAA for the 127 
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GEL were purchased from Fagron UK Ltd. The GEL was developed in a collaboration between 128 
the university and a product developer to the food industry based at Askham Bryan College (UK). 129 
The key nutritional information per 100 g was: energy 967 kJ, fat 0.0 g, carbohydrate 44.7 g, 130 
protein 15 g, salt 0.2 g. The GEL and WP were matched by total EAA content with both 131 
supplements providing 7.5 g of EAA (Hulmi et al. 2010; Ispoglou et al. 2016), and therefore not 132 
energy-matched. In order to consume 7.5 g of EAA during the WP experimental trial, participants 133 
had to ingest 15.2 g of whey protein which was obtained through consumption of 21.2 g of the WP 134 
powder. Thus, the WP supplement supplied participants with 1.3 g, 15.2 g, and 1.6 g of 135 
carbohydrate, protein, and fat respectively. The corresponding macronutrient composition for each 136 
50 ml GEL was 22 g, 7.5 g, and 0 g of carbohydrate, protein (all EAA), and fat respectively. The 137 
ratio of EAA in the GEL was the same as the 40% L-leucine formulation previously described by 138 
Ispoglou et al. (2016). Please see Table 2 for essential amino acid profiling in the GEL and WP 139 
supplements. 140 
Baseline appetite perceptions and a baseline blood sample were collected five minutes prior to 141 
each condition, with participants instructed to consume each supplement within a five-minute 142 
period. Once the breakfast was consumed, participants were asked to provide their final appetite 143 
perceptions.  144 
Body composition assessment  145 
Total-body fat mass, lean tissue mass, bone mineral content and percentage tissue fat mass 146 
(%TFM) values were measured by a total-body dual-energy X-ray absorptiometry (DXA) scan 147 
(GE Lunar iDXA, GE Healthcare, Madison, WI). Participants were scanned in a fasted, euhydrated 148 
state as per established guidelines (Sawka et al. 2007; Nana et al. 2012). Participants removed 149 
shoes and jewellery before receiving the scan, whilst adopting a supine position with arms to the 150 
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side in the semi-prone position and ankles supported with the Lunar ankle strap (0.5 cm space 151 
between the ankles). The values for the body composition outcomes were determined from the 152 
ratio of soft tissue attenuation of two X-ray energy beams for each pixel containing a minimal 153 
amount of soft tissue but no signiﬁcant bone (Mazess et al. 1990). In our laboratory, the in-vivo 154 
short-term precision (%CV) for total-body composition variables are 0.82% for fat mass, 0.51% 155 
for lean mass, 0.86% for percentage body fat and 0.60% for bone mineral content (Hind et al. 156 
2011). The machine was checked and calibrated on a daily basis in line with the manufacturer’s 157 
recommendations. All scanning and analysis procedures were performed by the same trained 158 
operator using the Lunar enCORE software package (version 15.0). 159 
 160 
Ad Libitum Breakfast  161 
The ALB was identical in each trial, with an energy density of 4.9 kJ/g and macronutrient 162 
composition of 59% carbohydrate, 18% protein and 23% fat. Meal preparation involved mixing of 163 
54 g of porridge oats (Oatso Simple Original, Quaker Oats) with 292 ml semi-skimmed milk. The 164 
mixture was then cooked in a microwave for two and a half minutes at 700 W. All participants 165 
were habitual breakfast users and accustomed to eating porridge. Participants consumed the 166 
breakfast in isolation to avoid any social influence on food intake. A bowl of the aforementioned 167 
meal was provided by an investigator and participants were instructed to eat until ‘comfortably 168 
full’, with no time limit set for eating. This bowl was replaced before the participant had emptied 169 
it, with minimal interaction and this process continued until the participant was comfortably full. 170 
Food intake was calculated as the weighted difference in food before and after eating (Deighton et 171 
al. 2016). 172 
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 173 
Appetite assessment 174 
Appetite perceptions (hunger, satisfaction, fullness and prospective food consumption) were 175 
measured using 100 mm visual analogue scales with descriptors anchored at each end (Flint et al. 176 
2000). Using these scales, a composite appetite score (CAS)(0 – 100) was calculated  using the 177 
following formula: CAS = ([hunger + prospective food consumption + (100 – fullness) + (100 – 178 
satisfaction)] / 4) (Stubbs et al. 2000).  179 
 180 
Blood sampling and biochemical analysis 181 
Participants rested in a semi-supine position for a minimum of five minutes before a cannula 182 
(Venflon, Becton Dickinson, Helsinborg, Sweden) was inserted into an antecubital vein by a 183 
trained phlebotomist. Blood samples were obtained at baseline (five min prior to each condition) 184 
and at five, 30, 60 min after supplement ingestion for the determination of plasma concentrations 185 
of insulin and PYY. At each time-point, samples were drawn into two pre-chilled 4.9 ml K3 186 
ethylenediaminetetraacetic acid vacutainers (Becton Dickinson, USA).  These vacutainers were 187 
spun at 1000 x g for 10 min at 4 °C. The plasma supernatant was then pipetted into Eppendorf 188 
tubes then stored −80 °C for subsequent analysis.  189 
Commercially available enzyme-linked immunosorbent assay kits were used to determine plasma 190 
concentrations of PYY (Millipore, Watford, UK), and insulin (IBL International GmbH, 191 
Germany). A decision was made to measure PYY and insulin since they are both raised in older 192 
people and are known to suppress appetite (Fraze et al. 1987; Parker et al. 2004; Hickson et al. 193 
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2016). To eliminate interassay variation, samples from each participant were analysed in the same 194 
run. The within-batch coefficients of variation for each assay were 5.3% and 9.3%, respectively. 195 
 196 
Statistical analyses 197 
Data were analysed using SPSS for Windows (Version 22.0, IBM Corp., Armonk, NY). Normality 198 
was assessed using the Shapiro-Wilk test. Time-averaged area under the curve (AUC) values were 199 
calculated using the trapezoidal method. One-way repeated measures ANOVA was used to 200 
examine trial-based differences in energy intake as well as baseline and AUC values for appetite 201 
perceptions and plasma analytes. Where significant effects were found, post-hoc analyses using 202 
the Holm-Bonferroni correction for multiple comparisons were performed. The sample sizes 203 
employed within this study were deemed sufficient to detect a significant difference in energy 204 
intake between trials as the primary outcome measure. Calculations were performed using 205 
G*Power with a meaningful difference in energy intake established as 500 kJ according to previous 206 
research, achieving 80% power with 10 participants, and based on the standard deviation for a 207 
similar ad libitum meal to that used within the present study. Results in the text and tables are 208 
shown as mean ± standard deviation (SD). In addition to significance testing and for all 209 
comparisons, Cohen’s d effect sizes were calculated and interpreted using the following 210 
thresholds: 0 – 0.2 (trivial), 0.2 – 0.5 (small), 0.5 – 0.8 (moderate), 0.8 – 1.2 (large), > 1.2 (very 211 
large) (Cohen, 1988). Cohen’s d expresses the mean difference between two groups in standard 212 
deviation units. For example, if groups do not differ by 0.2 SD, the difference would be trivial 213 
even if significant. For calculation of all effect sizes, the largest sample mean of the conditions 214 
compared was placed first in the relevant equation. For all effects sizes, 95% confidence intervals 215 
(CI) were also determined. Graphical representations of the results are depicted as mean ± standard 216 
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error of the mean (SEM) to avoid distortion of the figures. Statistical significance was accepted as 217 
P ≤ 0.05. 218 
 219 
Results  220 
 221 
Energy and macronutrient intakes  222 
Energy intake at the ALB was significantly different between trials (CON 1957 ± 713, WP 1413 223 
± 623, GEL 1963 ± 611 kJ; P < 0.0005), with both CON (P = 0.006; d = 0.81, 95% CI [0.30,1.32])  224 
and GEL higher than WP (P = 0.006; d = 0.89, 95% CI [0.33, 1.45]). CON and GEL were not 225 
significantly different (P = 0.942; d = 0.00, 95% CI [-0.27, 0.27]). After accounting for the energy 226 
content of the supplement, total energy intake was also significantly different between trials (P < 227 
0.0005; Figure 2). Total energy intake for the GEL was significantly higher than both CON (P = 228 
0.0006; d = 0.73, 95% CI [0.41, 1.05]) and WP (P = 0.0006; d = 1.10, 95% CI [0.60, 1.60]). CON 229 
and WP were not significantly different (P = 0.132; d = 0.32, 95% CI [-0.11 – 0.75]). The 230 
macronutrient contribution to energy intakes for the ALB and supplements singularly and 231 
combined are presented in Table 3. 232 
 233 
 234 
Appetite  235 
CAS did not differ between conditions at baseline (CON 73 ± 20, WP 69 ± 21, GEL 77 ± 18 mm, 236 
P = 0.120). A significant time-averaged appetite AUC effect was observed (CON 74 ± 20, WP 50 237 
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± 22, GEL 60 ± 16 mm, P = 0.002; Figure 3). Post-hoc analysis revealed that appetite ratings were 238 
significantly higher in CON vs WP (P = 0.015; d = 0.20, 95% CI [0.05, 0.35]). No significant 239 
differences were found for CON vs GEL (P = 0.076; d = 0.21, 95% CI [-0.03, 0.45]) and WP vs 240 
GEL (P = 0.076; d = 0.41, 95% CI [-0.05, 0.87]).     241 
 242 
Plasma PYY and insulin concentrations  243 
Baseline PYY and insulin values (Figures 4a and 4b) were not significantly different between 244 
conditions (P = 0.262 and P=0.452 for PYY and insulin respectively). Time-averaged AUC for 245 
PYY was significantly different between trials (CON 87 ± 13, WP 119 ± 27, GEL 97 ± 22 pg·mL-246 
1; P = 0.001; Figure 4a), with WP higher than CON (P = 0.009; d = 1.51, 95% CI [0.51, 2.51]) and 247 
GEL (P = 0.012; d = 0.89, 95% CI [0.25 – 1.53]). CON and GEL were not significantly different 248 
(P = 0.171; d = 0.55, 95% CI [-0.29 – 0.84]). Time-averaged AUC for insulin was not significantly 249 
different between trials (CON 20 ± 12, WP 31 ± 14, GEL 33 ± 17 µIU·mL-1; P = 0.095; Figure 250 
4b).  251 
 252 
 253 
254 
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Discussion  255 
 256 
This randomised cross over trial examined the acute effects of two protein-based oral nutritional 257 
supplements on appetite, selected appetite hormones and energy intake of older women. 258 
Administration of 7.5 g of EAA, the equivalent of approximately 15.2 g of WP isolate, was 259 
achieved via consumption of either a WP isolate beverage or an EAA gel, which were both given 260 
to participants one hour before the ALB. Our results demonstrated that when taking into account 261 
the energy and protein content of the supplements, the GEL facilitated an increase in both energy 262 
and protein intakes of older women during the ALB whilst WP facilitated an increase in protein 263 
intake alone. Consumption of the GEL did not affect appetite ratings or the concentration of the 264 
satiety hormone PYY, compared to the CON condition. Consumption of the WP isolate resulted 265 
in suppression of appetite as evidenced by significant reduction in CAS and increase in PYY. Thus, 266 
our data suggest that the current GEL formulation-based nutritional prototype may be more 267 
appropriate than WP for older women who would benefit from an increase in both energy and 268 
protein intakes per meal, without concomitant reductions in appetite. 269 
A significant decrease in energy intake at the ALB was observed in the WP condition alone 270 
compared to CON and GEL. After adjusting for the energy content of the supplements, no 271 
significant differences were observed between the WP and CON despite a reduction in total energy 272 
intake in the WP compared to the CON condition. The GEL resulted in significant increases in 273 
energy intake than both the CON and the WP conditions. These findings are relevant to the care 274 
of older adults who fail to meet both protein and energy recommendations (Bonnefoy et al. 2015; 275 
Sanson et al. 2018), and specifically older women who may be less likely to meet protein 276 
recommendations than men (Kerstetter et al. 2003; Morley et al. 2010; Farsijani et al. 2016). 277 
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Therefore, supplements provided in gel form as described in this study, may contribute to the 278 
management of age-related sarcopenia (Janssen et al. 2004a; Clark et al. 2010; Lang et al. 2010) 279 
since achieving optimal protein and energy intake is crucial for the maintenance of muscle mass 280 
and strength (Dahany et al. 2014; Thalacker‐Mercer et al. 2014; Baum et al. 2016). This would 281 
bear relevance for both institutionalised older adults (Sullivan et al. 1999; Elia 2006; Kaiser et al. 282 
2010; Elia 2015; Sanson et al. 2018) and community-dwelling populations (Rist et al. 2012; 283 
Geurden et al. 2015) since reports of malnutrition or risk of malnutrition exist for both populations.   284 
Taking into account that the protein content of the breakfast meal was 18%, participants in the 285 
CON condition consumed on average 21 g of protein at the ALB (Table 3). Notably, previous 286 
research suggests that protein intakes are significantly reduced at the breakfast meal with intakes 287 
of ~10 g (Tieland et al. 2012a). These lower levels of protein are not considered optimum for 288 
maximisation of muscle protein synthesis for our study population, who should be receiving at 289 
least 25-30 g of protein per meal (Moore et al. 2014; Phillips 2015; Lancha Jr et al. 2016) based 290 
on their body mass. Thirty grams of high quality protein per meal would in turn provide 291 
approximately 15 g of EAAs (Hulmi et al. 2010). Therefore, an alternative means to optimise 292 
muscle synthesis protein rates could be potentially achieved through administration of the amount 293 
of EAAs in approximately 30 g of protein rather than a larger bolus of dietary protein source, 294 
which will also provide non-essential amino acids that are not necessary for stimulation of muscle 295 
protein synthesis (Tipton et al. 1999). Ingestion of either the WP isolate or the GEL one hour 296 
before the ALB helped participants reach per meal protein intake recommendations however in 297 
the case of WP, this appeared to negatively affect energy intake. It could be argued that ingestion 298 
of the supplements immediately before the ALB may have also supressed appetite in the GEL. 299 
However, we have previously shown that the current EAA gel-based formulation, apart from being 300 
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palatable, is equally effective at facilitating an increase in both protein and energy intakes of older 301 
women when given either one hour or immediately before an ALB (Ispoglou et al. 2017).  302 
Both WP and GEL supplements had a high EAA content (7.5 g); a prerequisite for optimisation of 303 
muscle protein synthesis (Phillips et al. 2009; Breen et al. 2011; Churchward-Venne et al. 2014; 304 
Xu et al. 2015; Murphy et al. 2016; Phillips 2016; Hamarsland et al. 2017). Increased muscle 305 
protein synthesis rates are credited to a large extent to the higher leucine content in high quality 306 
proteins, which contributes to the regulation of muscle protein synthesis (Hamarsland et al. 2017). 307 
The WP condition received additional non-essential amino acids compared to the EAA gel, 308 
however our key objective was that both supplements were matched in total EAA content. 309 
Furthermore, the ratio of EAAs in the GEL was specifically optimised (i.e. higher leucine content) 310 
for older people (Katsanos et al. 2006; Xu et al. 2015; Murphy et al. 2016; Phillips 2016). 311 
Therefore, another advantage of the GEL was that it also facilitated a further increase in leucine 312 
content compared to the WP. Our previous work has demonstrated that ingestion of the current 313 
GEL formulation results in peak plasma concentration of amino acids within 30-60 minutes from 314 
ingestion, highlighting the efficient digestion and absorption rates of the GEL (Ispoglou et al. 315 
2017). 316 
It is generally agreed that protein-based oral nutritional supplements can be an effective means for 317 
improving functional capacity and body composition in older people (Dillon et al. 2009; Ferrando 318 
et al. 2010; Zhu et al. 2011; Tieland et al. 2012b; Bauer et al. 2015; Cramer et al. 2016; Ispoglou 319 
et al. 2016). Nevertheless, there is limited evidence of their beneficial impact on muscle mass and 320 
strength of predominantly healthy older people (Tieland et al. 2017). Similarly, studies in 321 
sarcopenic or clinical populations are not always associated with beneficial changes in muscle 322 
mass (Ferrando et al. 2010; Cramer et al. 2016). Compensatory caloric redistribution may explain 323 
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observed discrepancies since food protein sources and protein-based supplements have been 324 
reported to increase satiety and consequently reduce energy intake (Mollahosseini et al. 2017). In 325 
one of the largest and most comprehensive studies in malnourished men and women (Cramer et 326 
al. 2016), daily supplementation with  nutritional supplements containing 660 kcal and 40 g of 327 
protein, resulted in an increase in habitual energy intake from 1600 kcal.day-1 to approximately 328 
1800 kcal.day-1. Despite the positive increase in both energy and protein intakes, this study 329 
provides evidence of a partial caloric redistribution and potential appetite suppression since the 330 
average total energy intake should have exceeded 2200 kcal.day-1 should participants had 331 
maintained their habitual baseline energy intake. One of the key objectives of our study therefore 332 
was to investigate the impact of different forms of protein-based oral nutritional supplements 333 
matched in EAA content on appetite in older women. As a means to enhance the ecological validity 334 
of the current study, we intentionally avoided to match the beverages for volume. Water pre-loads 335 
have been shown to suppress appetite in subsequent meals only when intakes are large (~500 ml 336 
or above), and when beverages are ingested in closer proximity to a meal (i.e. <30 min) (Gray et 337 
al. 2003; Walleghen et al. 2007; Davy et al. 2008; Corney et al. 2016). Therefore, the small volume 338 
difference (150 ml) in our study between the GEL (50 ml) and WP (200 ml) is unlikely to have 339 
had an additional impact on either appetite or energy intake. In addition, it has been previously 340 
demonstrated that increasing the energy density of preload beverages is more influential at 341 
increasing energy intakes at follow-up ad libitum meals when beverage volume remains constant 342 
(i.e. 450 ml) (Gray et al. 2003). Nevertheless, energy intake at the ALB in the GEL condition was 343 
not compromised, despite the higher energy density compared to WP. This further emphasises the 344 
significance of our findings. Future research is advised to investigate the impact of nutritional 345 
supplementation on habitual protein intake in older populations since according to the Protein 346 
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Leverage Hypothesis dietary protein is more tightly regulated (Simpson et al. 2005; Martinez-347 
Cordero et al. 2012). 348 
Using a validated breakfast meal (Deighton et al. 2016), and in line with previous research 349 
(Ispoglou et al. 2017), our findings confirm that the GEL facilitated an increase in both protein 350 
and energy intakes, and did not suppress appetite compared to a powder-based WP supplement. 351 
Potential explanations for the suppression of appetite, as indicated by CAS and hormonal data, are 352 
longer digestion rates (Tremblay et al. 2015) and higher amino acid content (Moran et al. 2011) in 353 
the WP condition. Significant increases in PYY concentration, likely due to higher amino acid 354 
content in the WP, corroborate that the consequent reductions in energy intake are due to a satiating 355 
effect of whey protein (Mollahosseini et al. 2017) or dietary protein (Leidy et al. 2015; Phillips et 356 
al. 2016). Based on our findings, we suggest that the post-prandial increase in PYY may be the 357 
main reason for a suppression in subjectively reported appetite, which subsequently negatively 358 
affected energy intake at the ALB. Baseline PYY values are in alignment with previous literature 359 
(Hickson et al. 2016), demonstrating that post-prandial PYY levels are greater in older women 360 
compared to younger in response to a standard meal containing 2781 kJ and 27.5 g of protein. In 361 
our study, the highest post-prandial PYY values in response to the whey protein supplement were 362 
slightly lower than those for the latter study, however this was anticipated since the protein and 363 
energy content in our WP condition were lower than the corresponding values for Hickson et al. 364 
(2016). Insulin also acts as an appetite suppressant, whilst fasting values tend to be higher in older 365 
people (Fraze et al. 1987; Parker et al. 2004). Indeed, fasting insulin values in our study were 366 
typical of those expected for older people. As expected, insulin concentration increased following 367 
ingestion of both supplements, primarily in response to the carbohydrate and leucine content 368 
(Fraze et al. 1987; Greiwe et al. 2001; Miller et al. 2003; Leenders et al. 2011; Chowdhury et al. 369 
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2015) in WP and GEL. Nevertheless, no significant differences were observed between these two 370 
conditions. Therefore, it is unlikely that insulin played a role in appetite suppression under the 371 
current circumstances. We acknowledge that varying the time between ingestion of the 372 
supplements and consumption of a subsequent meal may result in different outcomes. However, 373 
we have previously demonstrated that the current gel results in similar responses in appetite and 374 
energy intakes regardless of whether it is taken alongside or an hour before an ad libitum breakfast 375 
(Ispoglou et al. 2017).  376 
In conclusion, the current GEL formulation brought synergistic benefits to both energy and protein 377 
intakes in older women and therefore may have advantages over a WP isolate when taken before 378 
a breakfast meal. Thus, such a supplement formulation may comprise an effective dietary strategy 379 
to address undernutrition and malnutrition in older women. Further research is required to confirm 380 
the generalisability and reproducibility of our findings in older clinical and non-clinical 381 
populations. There is a specific need to investigate whether acute or long-term daily nutritional 382 
intakes of free-living older people are affected when EAA-based nutritional supplements are taken 383 
alongside other main meals of varied composition.   384 
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Tables 648 
 649 
32 
 
Table 1: Descriptive characteristics for the study population. Data presented as mean ± SD. 650 
 651 
Variable n = 10 
Age (years) 69.2 ± 2.7 
Height (cm) 163.1 ± 3 
Body mass (kg) 60.8 ± 7.1 
BMI (kg·m2) 
Lean mass (kg) 
Fat mass (kg) 
Bone mineral content (kg) 
Percentage body fat (%) 
Systolic blood pressure (mmHg) 
Diastolic blood pressure (mmHg) 
Total cholesterol (TC) (mmol.L-1) 
High density lipoprotein (HDL)(mmol.L-1) 
Low density lipoprotein (mmol.L-1) 
Triglycerides (mmol.L-1) 
Ratio of TC/HDL 
Fasting blood glucose (mmol.L-1) 
22.8 ± 2.4 
37.7 ± 2.3 
20.4 ± 5.7 
2.2 ± 0.3 
33.1 ± 5.8 
124 ± 7.0 
80.7 ± 4.3 
5.42 ± 0.9 
1.8 ± 0.4 
3.4 ± 1.1 
1.3 ± 0.5 
3.6 ± 0.9 
5.2 ± 0.9 
33 
 
 652 
Table 2: Essential amino acid (EAA) profile in gel (GEL) and whey protein (WP) supplements. 653 
Adapted from Ispoglou et al. (2016) and Hulmi et al (2010). The GEL and WP were matched for 654 
total EAA content (~7.5 g each). 655 
 656 
 657 
 658 
 
Amino Acids GEL WP  GEL WP 
 (g/100g)                         (g/finished product) 
Leucine 40.0 12.2  3.0 1.9 
Isoleucine 11.0 6.1  0.8 0.9 
Valine 
Lysine 
Histidine 
Methionine 
Phenylalanine 
Threonine 
Tryptophan 
12.0 
12.0 
5.0 
2.0 
7.0 
11.0 
0 
5.9 
10.2 
Tr 
3.3 
3.0 
5.5 
1.8 
 0.9 
0.9 
0.4 
0.2 
0.5 
0.8 
0.0 
0.9 
1.6 
Tr 
0.5 
0.5 
0.8 
0.3 
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Table 3: Macronutrient content (in g) from ad libitum breakfast (ALB), and from ALB combined with supplement (SUPPL) for each 659 
condition. 660 
Control (CON), whey protein (WP), essential amino acid based gel (GEL), carbohydrate (CHO), protein (PRO), and fat (FAT). 661 
95% CI: 95% confidence interval of the mean difference between conditions. 662 
ES: Cohen’s d effect sizes. The effect sizes were calculated and interpreted using the following thresholds: 0 – 0.2 (trivial), 0.2 – 0.5 663 
(small), 0.5 – 0.8 (moderate), 0.8 – 1.2 (large), > 1.2 (very large).  664 
Macronutrient content in each supplement: GEL (CHO = 22.0 g; PRO = 7.5 g (all essential amino acids); FAT = 0 g) and WP (CHO = 665 
1.3 g; PRO = 15.2 g; FAT = 1.6 g) 666 
An asterisk (*) denotes significantly different from CON (P < 0.05). 667 
A section sign (§) significantly different between WP and GEL (P < 0.05). 668 
Data presented as mean ± SD. 669 
 670 
 
Dietary 
Variable 
CON WP GEL   WP   GEL  CON 
versus 
WP 
 CON 
versus 
GEL 
GEL 
versus 
WP 
 CON  
versus  
WP 
 CON  
versus  
GEL 
 
GEL  
versus  
WP 
ALB  
g 
 ALB + 
SUPPL g 
 ALB  
ES (95% CI) 
 ALB + SUPPL  
ES (95% CI) 
CHO 68.7 
(25.1)  
49.7 
(21.9) 
*§ 
68.9 
(21.5) 
§ 
 50.9 
(21.9) 
*§ 
90.9 
(21.5) 
*§ 
 0.8 
(-
41.1, 
3.1) 
0.0 
(-
21.8, 
22.1) 
0.9  
(-1.1, 
39.6) 
 0.8 
(-
39.1, 
4.3) 
0.8 
(-3.5, 
43.5) 
1.6  
(15.8, 
59.8) 
PR 21.0  
(7.6) 
15.2  
(6.7) 
*§ 
21.0  
(6.6)  
§ 
 30.4  
(6.7) 
* 
28.5  
(6.6)  
* 
 0.8 
(-
12.6, 
0.8) 
0.0 
(-6.7, 
6.7) 
0.9 
(-0.3, 
12.1) 
 1.3 
(2.6, 
16.0) 
1.1 
(0.8, 
14.2) 
0.3 
(-8.0, 
4.5) 
FAT 11.9  
(4.3) 
8.6  
(3.8) 
*§ 
11.9  
(3.7)  
§ 
 10.2  
(3.8) 
*§ 
11.9  
(3.7) 
*§ 
 0.8 
(-7.1, 
0.5)  
0.0 
(-3.7, 
3.8) 
0.9 
(-0.2, 
6.8) 
 0.4 
(-5.5, 
2.1)  
0.0 
(-3.7, 
3.7) 
0.5 
(-1.8, 
5.2) 
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Figures 671 
 672 
Figure 1: Schematic representation of the design of the study. Whey protein (WP), essential amino 673 
acid gel (GEL), control (CON), ad libitum breakfast (ALB). Black arrows = appetite rating 674 
assessment; syringe picture = blood samples.  675 
Figure 2: Energy intake including energy from supplements and the breakfast. Whey protein 676 
(WP), essential amino acid gel (GEL), control (CON), ad libitum breakfast (ALB), shaded area 677 
represents energy from supplements (SUPPL). Data are displayed as individual responses (a) and 678 
mean (SEM) (b), n=10. 679 
Figure 3: Composite appetite ratings for CON (▼), WP (●) and GEL (○).Values are mean (SEM), 680 
n=10.   681 
Figure 4: PYY (a) and insulin (b) concentrations over the 60-minute period CON (▼), WP (●) 682 
and GEL (○). Values are mean (SEM), n=10.  683 
 684 
